Department of Gastroenterology, University of California, San Francisco, San Francisco, CA.
Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA.
Hepatology. 2020 Jul;72(1):130-139. doi: 10.1002/hep.31027. Epub 2020 May 8.
In some states, liver transplantation (LT) for alcohol-associated liver disease (ALD) is covered by Medicaid only with documentation of abstinence and/or alcohol rehabilitation. Different Medicaid policies may affect the distribution of LT for ALD, particularly post-2011, as centers have adopted early (i.e., specific abstinence period not required) LT practices.
We surveyed Medicaid policies in all states actively performing LT and linked state policies to prospectively collected national registry data on LT recipients from 2002 to 2017 with ALD as the primary listing diagnosis. We categorized Medicaid policies for states as "restrictive" (requiring documentation of a specific abstinence period and/or rehabilitation) versus "unrestrictive" (deferring to center eligibility policies). Difference-of-differences analysis, comparing 2002-2011 versus 2012-2017, evaluated whether restrictive policies were associated with decreased proportion of LTs paid by Medicaid among patients with ALD post-2011. We performed sensitivity analyses to account for any differences by diagnosis of hepatocellular carcinoma, hepatitis C virus, nonalcoholic steatohepatitis, or Medicare insurance. We also performed a sensitivity analysis to account for any difference by prevalence of ALD among restrictive versus unrestrictive states. Of 10,836 LT recipients in 2002-2017, 7,091 were from 24 states in the restrictive group and 3,745 from 14 states in the unrestrictive group. The adjusted proportion (95% confidence interval) of LTs paid by Medicaid among restrictive versus unrestrictive states between 2002 and 2011 was 17.6% (15.4%-19.8%) versus 18.9% (15.4%-22.3%) (P = 0.54) and between 2012 and 2017, 17.2% (14.7%-19.7%) versus 23.2% (19.8%-26.6%) (P = 0.005). In difference-of-differences analysis, restrictive (versus unrestrictive) policies were associated with a 4.7% (0.8%-8.6%) (P = 0.02) absolute lower adjusted proportion of LTs for ALD paid by Medicaid post-2011.
Restrictive Medicaid policies are present in most states with active LT centers and are associated with lower proportions of LTs for ALD paid by Medicaid post-2011 compared to states with unrestrictive Medicaid policies. Reevaluation of Medicaid alcohol use policies may be warranted, to align more closely with contemporary center-level practices.
在某些州,接受肝移植(LT)治疗酒精性肝病(ALD)的患者只有在提供戒酒和/或酒精康复证明的情况下才能通过医疗补助计划(Medicaid)报销。不同的医疗补助计划可能会影响 LT 治疗 ALD 的分配,尤其是在 2011 年之后,因为中心已经采用了早期(即不需要特定的戒酒期)LT 治疗方法。
我们调查了所有积极开展 LT 的州的医疗补助计划,并将州政策与 2002 年至 2017 年期间使用 ALD 作为主要列出诊断的全国登记处 LT 受者的前瞻性收集数据联系起来。我们将医疗补助计划分为“限制型”(要求提供特定戒酒期和/或康复证明)和“非限制型”(由中心资格政策决定)。2002-2011 年与 2012-2017 年之间的差异分析比较了 2011 年后,限制性政策是否与接受 ALD 治疗的患者中由医疗补助计划支付的 LT 比例降低有关。我们进行了敏感性分析,以考虑肝癌、丙型肝炎病毒、非酒精性脂肪性肝炎或医疗保险诊断的任何差异。我们还进行了敏感性分析,以考虑限制型和非限制型州之间 ALD 患病率的任何差异。在 2002-2017 年期间接受 LT 的 10836 名患者中,24 个州的患者属于限制组,有 7091 人,14 个州的患者属于非限制组,有 3745 人。2002 年至 2011 年期间,限制型与非限制型州之间由医疗补助计划支付的 LT 的调整比例(95%置信区间)分别为 17.6%(15.4%-19.8%)和 18.9%(15.4%-22.3%)(P=0.54),2012 年至 2017 年期间分别为 17.2%(14.7%-19.7%)和 23.2%(19.8%-26.6%)(P=0.005)。差异分析表明,与非限制型政策相比,限制型(而非非限制型)政策与 2011 年后由医疗补助计划支付的 ALD 的 LT 比例绝对降低了 4.7%(0.8%-8.6%)(P=0.02)。
大多数有积极 LT 中心的州都存在限制型医疗补助政策,与非限制型医疗补助政策相比,这些政策与 2011 年后由医疗补助计划支付的 ALD 的 LT 比例较低有关。可能需要重新评估医疗补助计划的酒精使用政策,以使其更符合当前的中心一级实践。